Kerri Weingard | Cofounder, VP & Global COO
Verified Clinical Trials

Kerri Weingard is a founding partner and the Global Chief Operating Officer at Verified Clinical Trials (VCT), the world’s largest global research subject database focused on reducing dual enrollment and preventing protocol violations in clinical trials. With a deep commitment to enhancing patient safety, data integrity, and the efficiency of clinical research, Kerri has played a pivotal role in shaping the landscape of clinical trial management, particularly in vaccine research. Under her leadership, Verified Clinical Trials has pioneered innovative approaches to clinical trial monitoring and patient enrollment, enabling faster, more accurate, and more reliable vaccine development. By leveraging cutting-edge technologies and implementing best practices, Kerri has not only advanced the field of vaccine research but also revolutionized how clinical trials are conducted and managed globally. Her strategic vision and unwavering focus on improving clinical trial outcomes have contributed to reducing risks, optimizing processes, and ensuring the integrity of clinical research data. Kerri’s expertise in clinical research is rooted in her extensive experience as a nurse practitioner and her academic foundation, holding a Master’s Degree in Science from Stony Brook University. Prior to founding VCT, Kerri conducted over 500 clinical trials as a research administrator and sub-investigator, gaining invaluable insights into the challenges and intricacies of clinical trials. With more than 20 years in the clinical research industry, she has developed a reputation for combining a deep understanding of healthcare with operational excellence. A dedicated professional, Kerri is an active member of several prominent industry organizations, including the American Society for Clinical Pharmacology and Therapeutics, the Drug Information Association, and the Association of Clinical Research Professionals. Her contributions to these communities have positioned her as a thought leader in clinical research, particularly in the areas of clinical trial optimization and patient safety.